Literature DB >> 11448353

Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: experience with 60 cases.

M M Hsu1, R L Hong, L L Ting, J Y Ko, T S Sheen, P J Lou.   

Abstract

OBJECTIVE: To analyze the factors affecting overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site after a full course of radiotherapy.
DESIGN: Retrospective analysis of 60 consecutive patients treated by surgical resection of the recurrent tumors, with a mean follow-up of 43.1 months (range, 19-96 months).
SETTING: Academic tertiary referral center.
RESULTS: The overall survival and locoregional relapse-free survival were 56% and 60% at 2 years, respectively, and 30% and 40% at 5 years. Twenty-nine (81%) of 36 patients died with uncontrolled local disease. The T stage of the recurrent tumors appeared to be an important prognostic factor. Age, sex, pathologic findings, and disease-free interval (time between previous radiotherapy and local recurrence) were not significant prognosis-affecting factors by the log-rank test. Multivariate analysis showed that patients with recurrent tumors of undifferentiated carcinoma, sarcoma, or small cell carcinoma had unfavorable prognoses. Uncontrolled local disease and the emergence of distant metastasis predicted grave results as well. Postoperative irradiation showed some benefit to patients, but the difference was not statistically significant.
CONCLUSIONS: The T stage of the recurrence was the prominent prognosis-affecting factor in patients with recurrent nasopharyngeal carcinoma who received salvage surgery. Patients with local recurrence should be carefully selected for the salvage surgery. We recommend this surgery for patients with rT1, rT2, or limited rT3 lesions. The results of surgical resection in terms of local control and overall survival were slightly better than those of high-dose reirradiation, with fewer late complications.

Entities:  

Mesh:

Year:  2001        PMID: 11448353

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  7 in total

Review 1.  Stereotactic radiosurgery for patients with cancer of the head and neck.

Authors:  Edward Gardner; Mark E Linskey; José A Peñagarícano; Ehab Y Hanna
Journal:  Curr Oncol Rep       Date:  2003-03       Impact factor: 5.075

2.  Outcomes of Recurrent Nasopharyngeal Carcinoma Patients Treated With Salvage Surgery: A Meta-Analysis.

Authors:  Yekai Feng; Zhimei Dai; Ruicheng Yan; Feng Li; Xiaosheng Zhong; Haoxin Ye; Caiqing Chen; Shaochong Fan; Cheng Qing; Yong Pan; Haiying Sun
Journal:  Front Oncol       Date:  2021-10-08       Impact factor: 6.244

3.  Salvage surgery for recurrent nasopharyngeal carcinoma.

Authors:  Giovanni Danesi; Elisabetta Zanoletti; Antonio Mazzoni
Journal:  Skull Base       Date:  2007-05

4.  Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy.

Authors:  Y-M Tian; Y-H Tian; L Zeng; S Liu; Y Guan; T-X Lu; F Han
Journal:  Br J Cancer       Date:  2013-12-12       Impact factor: 7.640

Review 5.  Salvage surgery for nasopharyngeal cancer.

Authors:  Raymond K Tsang; William I Wei
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2015-10-24

Review 6.  Recurrent Nasopharyngeal Cancer: Critical Review of Local Treatment Options Including Recommendations during the COVID-19 Pandemic.

Authors:  Michaela Svajdova; Marian Sicak; Pavol Dubinsky; Marek Slavik; Pavel Slampa; Tomas Kazda
Journal:  Cancers (Basel)       Date:  2020-11-25       Impact factor: 6.639

7.  5-year outcomes of salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma.

Authors:  Andrew Thamboo; Vishal S Patel; Peter H Hwang
Journal:  J Otolaryngol Head Neck Surg       Date:  2021-02-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.